| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |